2023
Halahakoon, D.C., Kaltenboeck, A., … , Browning, M. (in press) Pramipexole Enhances Reward Learning by Preserving Value Estimates. Biological Psychiatry
DOI: 10.1016/j.biopsych.2023.05.023
Jauhar, S., Cowen, P. J., & Browning, M. (2023). Fifty years on: Serotonin and depression. Journal of Psychopharmacology (Oxford, England), 2698811231161813.
DOI: 10.1177/02698811231161813
2022
Chapman, N., Browning, M., …, Mansoori, P. (in press) Setting national research priorities for Difficult-to-Treat Depression in the UK between 2021-2026. Journal of Global Health
DOI: 10.7189/jogh.12.09004
Kaltenboeck, A., Halahakoon, D. C., Harmer, C. J., Cowen, P., & Browning, M. (2022). Enhanced taste recognition following subacute treatment with the dopamine D2/D3 receptor agonist pramipexole in healthy volunteers. The International Journal of Neuropsychopharmacology
DOI: 10.1093/ijnp/pyac030
Au-Yeung, S., …, Browning, M. (2022) PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evidence Based Mental Health 25(2).
DOI: 10.1136/ebmental-2021-300282
2021
Browning, M., … Dawson, G. R. (2021). The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): An open-label, randomised controlled trial. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 46(7), 1307–1314.
DOI: 10.1038/s41386-021-00981-z
